These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35976174)

  • 1. Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease.
    Gallegos Aragon K; Ray G; Conklin J; Stever E; Marquez C; Magallanes A; Anderson J; Jakeman B
    Am J Health Syst Pharm; 2022 Nov; 79(22):2026-2031. PubMed ID: 35976174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK; Olsen CJ; Voelker J; Wander C
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
    Tran JN; Kao TC; Caglar T; Stockl KM; Spertus JA; Lew HC; Solow BK; Chan PS
    J Manag Care Spec Pharm; 2016 Aug; 22(8):901-8. PubMed ID: 27459652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
    Malvestutto C
    J Fam Pract; 2022 Jul; 71(6 Suppl):S58-S62. PubMed ID: 35960946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
    Boettiger DC; Chattranukulchai P; Avihingsanon A; Chaiwarith R; Khusuwan S; Law MG; Ross J; Kiertiburanakul S
    PLoS One; 2021; 16(9):e0256926. PubMed ID: 34499685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease.
    McLaughlin MM; Durstenfeld MS; Gandhi M; Greene M; Ma Y; Beatty AL; Hsue PY
    AIDS; 2023 Nov; 37(14):2179-2183. PubMed ID: 37498162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB; Nordestgaard BG
    JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.
    Anderson TS; Wilson LM; Sussman JB
    JAMA Intern Med; 2024 Aug; 184(8):963-970. PubMed ID: 38856978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
    Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
    J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF; Marrs JC; Saseen JJ
    Ann Pharmacother; 2016 Jan; 50(1):17-21. PubMed ID: 26416950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients Living With HIV Are Less Likely to Receive Appropriate Statin Therapy for Cardiovascular Disease Risk Reduction.
    Emmons RP; Hastain NV; Miano TA; Schafer JJ
    J Pharm Pract; 2022 Aug; 35(4):568-572. PubMed ID: 33678059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
    Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
    JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.
    Dorsch MP; Lester CA; Ding Y; Joseph M; Brook RD
    J Am Heart Assoc; 2019 Nov; 8(22):e014709. PubMed ID: 31707943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients.
    Blackman AL; Pandit NS; Pincus KJ
    HIV Med; 2020 Mar; 21(3):135-141. PubMed ID: 31876122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.